Anemia treatment before heart surgery for endocarditis
Part of Heart & circulation clinical trials.
This study tests whether treating anemia (low red blood cells) with iron, vitamins, and medication before heart surgery helps people recover better after surgery for a heart valve infection (endocarditis). If you have endocarditis and are scheduled for heart surgery, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have an infection of the heart valves (endocarditis).
- You are planning to have heart surgery (not an emergency).
- You do not have a known allergy to intravenous iron, folic acid, vitamin B12, or erythropoietin.
- You are not already in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study keeps a detailed record of adults with infective endocarditis (a serious heart valve infection) who are undergoing cardiac surgery. The information may help doctors understand patterns of care and outcomes, and improve future treatment decisions.
This study looks at people who have heart surgery to treat a serious heart infection called infective endocarditis. It helps doctors learn more about how these surgeries work and what affects recovery.
This trial studies a program to manage blood levels before, during, and after heart surgery. It may help reduce the need for blood transfusions and improve recovery.
This study tests whether giving iron and a blood-boosting medicine (EPO) helps patients with bacterial heart valve infections who have low red blood cells. The goal is to see if it speeds recovery and improves how patients feel.
This trial is testing whether giving iron plus vitamin C before heart surgery can reduce the need for blood transfusions. It is for people with low iron and anemia who are scheduled for bypass or valve surgery.
This trial tests a combined treatment plan to improve anemia (low blood count/iron levels) before and around the time of major elective heart surgery. It may help reduce the need for blood transfusions and support safer recovery.
Hear when a new Infective Endocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.